Reasons for Patient Withdrawal
Your patient didn’t wake up this morning and just decide to withdraw—this has been a long time coming.
Patients in clinical trials don’t just decide to withdraw on a single day. There are almost no single events that will cause a patient to withdraw without prior warning. For example, a massive adverse reaction, an argument with a staff member, or something traumatic might lead to an immediate withdrawal, but these are rare.
Very often, however, patients withdraw because of a thousand tiny cuts.
These can include having to drive too far, dealing with excessive paperwork, adhering to complex rules, or not fully understanding the implications of the clinical trial.
Patients may withdraw from your trials, and for a proportion of patients it’s inevitable. It’s important to follow up with them to understand why they withdrew—not just for the trial at hand but also to inform future trials and keep iterating to drive down withdrawal rates .
You’ll be able to see the trend lines. Some of the reasons I’ve noticed recently include:
- “There’s a lot of time you’re not paying me for.”
- “I feel better already, so why should I keep going?” (the antibiotic conundrum).
- “The trial is just a pain to be part of.”
- “The drug doesn’t seem to be having any effect.”
- “I must be on the placebo.”
All these are reasons people drop out of clinical trials. It’s crucial to know what those reasons are and address them well in advance to avoid losing participants.
We all know that every time you start losing patients in your clinical trial, you’re essentially starting over again.
What are you doing to ensure your patients stay in your clinical trials and to address their pain points before they reach the point of wanting to quit?
Making Patients Heard Throughout the Research Journey
Clinical research only succeeds when patients are actively involved at every stage. Too often, their perspectives are a last-minute idea or ignored altogether. This limits study relevance, enrolment success, and real-world impact. Early and continued patient input makes research more ethical, efficient, and effective.
A lack of direct patient involvement results in trial designs that fail to meet participant needs and leads to burdensome protocols, recruitment challenges, and retention issues, while patient engagement creates studies that are patient-centred from concept to completion.
Patient input strengthens clinical research by identifying barriers, improving accessibility, and shaping trial endpoints that matter to patients. Researchers who actively listen gain insights that drive practical improvements in trial conduct and data quality.
Embedding Patient Voices Early
Patient engagement should begin before study protocols are finalised. Asking patients how they experience their condition, what matters most in their treatment, and what barriers they face to participation informs better trial design. Understanding patient needs means designing studies that align with their daily lives, rather than expecting participants to accommodate complex, impractical trial protocols. Instead of assuming what is feasible, researchers should invite patients into the discussion and treat them as essential contributors. When patients share their experiences, they highlight logistical and emotional challenges that might otherwise go unnoticed.
Many research protocols are structured around clinical convenience rather than patient practicality. By engaging patients before study initiation, investigators gain valuable insight into what might deter or encourage participation. Long visit schedules, excessive travel, and overly complex procedures are often cited as key barriers. Addressing these factors early helps in structuring trials that patients can realistically commit to. Researchers must ask themselves: how easy is it for a patient to take part in this study? If the process feels cumbersome or disruptive, participation rates will suffer.
Engaging patient advocates and advisory groups can significantly enhance study design. Their input ensures that endpoints align with real patient concerns and that recruitment materials are understandable and transparent. This collaborative approach results in stronger patient enrolment, greater study compliance, and improved data quality. Patients who feel their voices matter are more likely to remain engaged throughout the research process, contributing to more robust and meaningful findings.
Sustaining Engagement Throughout Research Collaboration
It’s not enough to seek patient input at the outset and move on. Ongoing collaboration ensures studies remain patient-friendly. Patients should have channels to share their experiences as the trial progresses. Engagement should not be a one-time consultation but a continuous effort to ensure that research remains aligned with real-world patient experiences. Regular check-ins, patient surveys, and advisory boards can help trial teams stay connected to participant concerns.
Research collaboration benefits from patient advisory groups that review study updates, participant materials, and evolving challenges. Researchers should actively seek feedback on patient experience throughout the study lifecycle. When patients feel heard, they are more likely to stay engaged and provide valuable insights on ways to optimise the trial process.
Effective communication is crucial. Many trials use complex language that alienates patients, making it difficult to understand procedures, risks, and expectations. Study materials should be jargon-free, clear, and adapted to different levels of health literacy. Too often, patients report feeling confused or overwhelmed by research documents. If information is not accessible, retention and engagement rates decline. Researchers should focus on clarity, transparency, and responsiveness to patient queries, ensuring that participants always feel informed and valued.
Improving Accessibility and Reducing Burdens
One of the biggest reasons for patient dropout is difficulty. Studies designed without patient input impose impractical travel, time, or procedural burdens. Patients are already dealing with the complexities of managing their condition; they shouldn’t have to navigate a demanding research process. Easier participation improves both recruitment and retention.
Researchers need to explore flexible participation models. Home-based and virtual visits can reduce unnecessary travel and make trials more accessible to a wider demographic. Remote monitoring technologies allow real-time data collection without frequent site visits. Reimbursements and logistical support remove barriers for those who do have to travel.
Underrepresentation remains a significant issue. Many marginalised populations face additional obstacles due to financial constraints, language barriers, or mistrust. Inclusive recruitment strategies must be implemented for research to benefit all patients, not just those with the means to participate. Accessibility creates more representative and equitable trials.
Another key factor in accessibility is the burden of study procedures. Long hospital stays, excessive testing, and cumbersome data collection methods discourage participation. Where possible, trial teams should streamline procedures, focusing on what is essential for scientific validity while minimising unnecessary patient effort. A patient-centred approach considers both the scientific goals and the human experience of participating in research.
Recognising Patients as Partners
Patients contribute valuable expertise about their condition. They are not just participants but partners in research. Researchers must keep them updated on study outcomes and the impact of their contributions. Far too often, patients feel like passive subjects rather than active collaborators. Research teams must recognise them as equal stakeholders to strengthen trust with the patient community.
Patients deserve to know how their participation has contributed to research. Researchers should provide summaries of study results to demonstrate transparency and make sure participants are not left wondering about their involvement. A lack of feedback discourages future participation and undermines the credibility of clinical research.
Research collaboration shouldn’t end with the study. Continued dialogue with patient advocacy groups improves future research initiatives. Patients can become powerful advocates for clinical research and help spread awareness and encourage others to participate. Their experiences make sure trials remain relevant, practical, and patient-centred by providing insight that researchers may not otherwise consider, ensuring that trials remain relevant, practical, and patient-centred.
A patient-first approach to research enhances both study outcomes and the broader clinical trial landscape. By ensuring patient voices are heard from the earliest planning stages to post-study communication, researchers build more effective and ethical trials.
Keith Berelowitz | Founder & CEO
Keith Berelowitz is the Founder of pRxEngage, a company redefining patient engagement and retention in clinical trials using living experience, proven methods, and AI.
